rss
Evid Based Mental Health 12:65-68 doi:10.1136/ebmh.12.3.65
  • EBMH Notebook

The failure to know what isn't known: negative publication bias with lamotrigine and a glimpse inside peer review

Table 1 Published and unpublished randomised clinical trials of lamotrigine in bipolar disorder
Study Diagnosis Design No Duration (weeks) Scale Outcome Result Published
SCAA2008 Mania LTG vs Li vs Pla 216 3 MRS LTG −9.3±10.9 Failed* No
Li −10.7±11.6
Pla −9.5±10.5
SCAA2009 Mania LTG vs Li vs Pla 229 6 MRS LTG −11.6±14.0 Negative† No
Li −15.6±13.0
Pla −11.4±12.3
SCAA2010 Bipolar LTG vs Pla 206 10 HDRS LTG −10.6±8.3 Negative‡ No
depression Pla −10.2±8.1
SCA40910 Bipolar LTG vs Pla 257 8 MADRS LTG −12.2 Negative‡ No
depression Pla −11.2
SDs not provided
SCAB2001 Bipolar depression LTG vs Pla 195 7 HDRS LTG (200 mg/day) −10.5±8.1 (p = 0.08) Negative‡ Yes
LTG (50 mg/day) −9.3±8.9 (p = 0.24)
Pla −7.8±7.9
SCAB2005 Rapid LTG vs Pla 137 32 TIME Median survival time Negative‡ No
cycling LTG 142 days
Pla 133 days
p = 0.73
SCAA2012 Rapid LTG vs Pla 182 34 TIME Median survival time Negative‡ Yes
cycling LTG 126 days
Pla 79 days
p = 0.18
SCAB2003 Prophylaxis LTG vs Li vs Pla 463 72 TIME Median survival time Positive Yes
LTG 200 days
Li 170 days
Pla 93 days
p = 0.029 for both Li and LTG
SCAB2006 Prophylaxis LTG vs Li vs Pla 175 72 TIME Median survival time Positive Yes
LTG 141 days
Li 292 days
Pla 85 days
p = 0.02 for LTG
p = 0.003 for Li
  • Source for unpublished data: www.gsk.com (accessed 11 June 2009).

  • *Lamotrigine and lithium (active control) were equivalent to placebo, thus no information for or against lamotrigine efficacy can be concluded.

  • †Lamotrigine was equivalent to placebo but lithium was more effective than placebo.

  • ‡Lamotrigine was equivalent to placebo in an adequately powered study to demonstrate modest effect sizes.

  • HDRS, Hamilton Depression Rating Scale; Li, lithium; LTG, lamotrigine; MADRS, Montgomery Asberg Depression Rating Scale; MRS, Mania Rating Scale from SADS-C; Pla, placebo; TIME, time to intervention with psychotropic medications due to full relapse or initiation of relapse into mood episodes.

  • Reprinted with permission from the Medscape Journal of Medicine 2008;10:211. Available at http://www.medscape.com/viewarticle/579046 © 2008 Medscape.

This Article

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.